Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis

Techniques in Coloproctology

Volumn 20, Issue 8, 2016, Pages 517-535

  Doleman, B ^a   Mills, K T ^b   Lim, S ^c   Zelhart, M D ^c   Gagliardi, G ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMI; Body weight; Colorectal cancer; Mortality; Obesity; Systematic review

Indexed keywords

ADULT; AGED; BODY MASS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CAUSE OF DEATH; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UNDERWEIGHT; BODY WEIGHT; COLORECTAL NEOPLASMS; COMPLICATION; EPIDEMIOLOGY; META ANALYSIS; MORTALITY; SURVIVAL RATE; TUMOR RECURRENCE;

BODY MASS INDEX; CAUSE OF DEATH; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; SURVIVAL RATE; THINNESS;

EID: 84976321897     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-016-1498-3     Document Type: Review

References (61)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Cunningham D, Atkin W, Lenz HJ et al (2010) Colorectal cancer. Lancet 375:1030–1047
3. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomark Prev 16:2533–2547
4. Dignam JJ, Polite BN, Yothers G et al (2006) Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 98:1647–1654
5. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR (2009) Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis. Asian Pac J Cancer Prev 10:815–821
6. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK (2011) The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomark Prev 20:1410–1420
7. Alipour S, Kennecke HF, Woods R et al (2013) Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer. J Gastrointest Cancer 44:203–210
8. Boyle T, Fritschi L, Platell C, Heyworth J (2013) Lifestyle factors associated with survival after colorectal cancer diagnosis. Br J Cancer 109:814–822
9. Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968–977
10. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269
11. World Health Organization (1995) Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452
12. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Multiple comparisons within a study. In: Introduction to meta-analysis. Wiley, West Sussex, United Kingdom, pp 239–242
13. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Initiative Strobe (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45:247–251
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
15. Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
16. Meyerhardt JA, Tepper JE, Niedzwiecki D et al (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22:648–657
17. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM (2011) Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30:42–52
18. Chin CC, Kuo YH, Yeh CY et al (2012) Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol 18:4191
19. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A (2006) Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 17:63–70
20. Kuiper JG, Phipps AI, Neuhouser ML et al (2012) Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 23:1939–1948
21. Kuo YH, Lee KF, Chin CC, Huang WS, Yeh CH, Wang JY (2012) Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer? Int J Colorectal Dis 27:1625–1635
22. Moghimi-Dehkordi B, Safaee A, Zali MR (2008) Prognostic factors in 1138 Iranian colorectal cancer patients. Int J Colorectal Dis 23:683–688
23. Meyerhardt JA, Catalano PJ, Haller DG et al (2003) Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 98:484–495
24. Prizment AE, Flood A, Anderson KE, Folsom AR (2010) Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev 19:2229–2237
25. Sinicrope FA, Foster NR, Yothers G, Benson A, Seitz JF, Labianca R (2013) Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 119:1528–1536
26. You JF, Tang R, Changchien CR et al (2009) Effect of body mass index on the outcome of patients with rectal cancer receiving curative anterior resection: disparity between the upper and lower rectum. Ann Surg 249:783–787
27. Fedirko V, Romieu I, Aleksandrova K et al (2014) Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer 135:1949–1960
28. Pelser C, Arem H, Pfeiffer RM et al (2014) Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer 120:1540–1547
29. Hede P, Sörensson MÅ, Polleryd P, Persson K, Hallgren T (2015) Influence of BMI on short-term surgical outcome after colorectal cancer surgery: a study based on the Swedish national quality registry. Int J Colorectal Dis 30:1201–1207
30. Flegal KM, Graubard BI, Williamson DF, Gail MH (2007) Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298:2028–2037
31. O’Gorman P, McMillan DC, McArdle CS (2000) Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37:36–40
32. Tan BH, Fearon KC (2008) Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 11:400–407
33. Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309:71–82
34. Van Gaal LF, Mertens IL, Christophe E (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880
35. Brandstedt J, Wangefjord S, Nodin B, Gaber A, Manjer J, Jirstrom K (2012) Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ 3:23
36. Griggs JJ, Mangu PB, Anderson H et al (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 30:1553–1561
37. Vargas HD (2011) Colon and rectal surgery in the obese patient. Clin Colon Rectal Surg 24:203
38. Clancy C, O’Leary DP, Burke JP et al (2015) A meta-analysis to determine the oncological implications of conversion in laparoscopic colorectal cancer surgery. Colorectal Dis 17:482–490
39. McTiernan ANNE (2005) Obesity and cancer: the risks, science, and potential management strategies. Oncology 19:871–881
40. Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86:s836–s842
41. Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56:1304–1319
42. Frezza EE, Wachtel MS, Chiriva-Internati M (2006) Influence of obesity on the risk of developing colon cancer. Gut 55:285–291
43. Richardson LC, Pollack LA (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2:48–53
44. Wolpin BM, Meyerhardt JA, Chan AT et al (2009) Insulin, the insulin like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176–185
45. Fuchs CS, Goldberg RM, Sargent DJ et al (2008) Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res 14:8263–8269
46. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B (2008) Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci 53:2486–2494
47. Payne JE, Meyer HJ (1995) The influence of other diseases upon the outcome of colorectal cancer patients. Aust NZ J Surg 65:398–402
48. Brändstedt J, Wangefjord S, Nodin B et al (2014) Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study. PLoS One 9:e98964. doi:10.1371/journal.pone.0098964
49. Hughes LA, Williamson EJ, van Engeland M et al (2012) Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 41:1060–1072
50. Morikawa T, Kuchiba A, Lochhead P et al (2013) Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. Cancer Res 73:1600–1610
51. Wichmann MW, Müller C, Hornung HM, Lau-Werner U, Schildberg FW (2001) Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88:1092–1098
52. Power ML, Schulkin J (2008) Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr 99:931–940
53. Geiger TM, Muldoon R (2011) Complications following colon rectal surgery in the obese patient. Clin Colon Rectal Surg 24:274–282
54. Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828
55. Lee J, Meyerhardt JA, Giovannucci E, Jeon JY (2015) Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS One 10:e0120706
56. Sinicrope FA, Foster NR, Sargent DJ, O’Connell MJ, Rankin C (2010) Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 16:1884–1893
57. Lee CMY, Huxley RR, Wildman RP, Woodward M (2008) Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 61:646–653
58. Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379–384
59. Sandler RS, Halabi S, Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883–890
60. Boereboom CL, Williams JP, Leighton P, Lund JN (2015) Exercise prehabilitation in Colorectal Cancer Delphi Study Group. Forming a consensus opinion on exercise prehabilitation in elderly colorectal cancer patients: a Delphi study. Tech Coloproctol 19:347–354
61. Boereboom CL, Doleman B, Lund JN, Williams JP (2016) Systematic review of pre-operative exercise in colorectal cancer patients. Tech Coloproctol 20:81–89